Skip to content

Released Aug 7, 2017, before the open

10-Q filed Aug 7, 2017, 38 days after period end · 0001144204-17-040693

Q2 2017 · 10-Q
Revenue$0.00no prior Q2 2016 on fileno prior Q1 2017 on file
Net Income-$6.09MN/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.31N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$6,140,618N/M
Operating Cash Flowderived-$4,700,559N/M
Free Cash Flowderived-$4,700,559N/M

What the release said

The release

Same quarter

MetricQ2 2017Q2 2016Q2 2015Q2 2014
Revenue$0.00———
Net Income-$6.09M-$5.76M-$4.25M-$6.97M
EPS Diluted-$0.31-$0.32-$0.26-$0.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR